Why Is It Moving? Analyzing The Upward Movement in F-star Therapeutics's Stock Today

F-star Therapeutics's Stock Price And Volume Action

F-star Therapeutics's FSTX stock is trading up 24.69% to a price of $13.79. Thursday the stock has been traded at a volume of 147.87 thousand, about 183.67% of its recent 30-day volume average of 80.51 thousand.

Why It's Moving

Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Immutep, F-star Gain On Positive News On Rival's Candidate: Immutep, an Australian biotech that develops immunotherapies for cancer and autoimmune disorders, and U.K.-based F-star, a clinical-stage biopharma developing tetravalent bispecific antibodies for cancer treatment, are reacting to a positive readout from Bristol-Myers Squibb BMY. Also F-Star Therapeutics shares are trading higher after Laidlaw & Co initiated coverage on the stock with a Buy rating and a price target of $32 per share.

Perspective On Recent Price Action

The 50-day moving average price of F-star Therapeutics's stock was $9.57 when this article was published. The stock reached a high of $12.99 and a low of $6.61 in the past 52 weeks.

Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.